Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.
Also called NCT02129634
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 136 participants
- Sponsor
- Registry
-
NCT02129634
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Singapore
- Registry status
- Completed
Technical summary
Registry record NCT02129634. Randomized; double masking; primary purpose treatment. Start 2013-12-27 (actual); primary completion 2018-10-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial
- Acronym
- SINGA-PACLI
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- CB-PTA
- Intervention (Device)
- DEB-PTA
- Lead sponsor
- Singapore General Hospital
- Collaborator
- Tan Tock Seng Hospital
- Collaborator
- Duke-NUS Graduate Medical School
- Collaborator
- Singapore Clinical Research Institute
Record details
- Record id
cardio:ct-nct02129634- Content hash
8012b60345495b79be530b434a1d8669f11119085f6dd0028a5f5de3d1e49e4b